Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Watson

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Gut|November 24, 1999
A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growthS A Watson, T M Morris, A Varro, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenograftsE Jacobs, S A Watson, I O Ellis, et al.
British Journal of Cancer|November 1, 1996
Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites modelS A Watson, T M Morris, S L Parsons, et al.
Journal of the National Cancer Institute|June 19, 1991
Intracellular gastrin in human gastrointestinal tumor cellsS A Watson, L G Durrant, P M Wencyk, et al.
The British Journal of Surgery|February 1, 1997
Matrix metalloproteinasesS L Parsons, S A Watson, P D Brown, et al.
International Journal of Cancer|June 22, 2000
Transforming growth factor-alpha-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathwayS A Watson, K E Robinson, D McWilliams, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2005
Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine modelsR N Williams, S L Parsons, T M Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumideS A Watson, D L Morris, L G Durrant, et al.
Experimental and Molecular Pathology|February 1, 1981
Rubratoxin B hepatotoxicity: an electron microscopic studyV G Lockard, S A Watson, M Y Siraj, et al.
Anticancer Research|January 1, 1993
Interactions between oestradiol and danazol on the growth of gastrointestinal tumour cellsS A Watson, D M Crosbee, K L Dilks, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Gut|November 24, 1999
A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growthS A Watson, T M Morris, A Varro, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenograftsE Jacobs, S A Watson, I O Ellis, et al.
British Journal of Cancer|November 1, 1996
Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites modelS A Watson, T M Morris, S L Parsons, et al.
Journal of the National Cancer Institute|June 19, 1991
Intracellular gastrin in human gastrointestinal tumor cellsS A Watson, L G Durrant, P M Wencyk, et al.
The British Journal of Surgery|February 1, 1997
Matrix metalloproteinasesS L Parsons, S A Watson, P D Brown, et al.
International Journal of Cancer|June 22, 2000
Transforming growth factor-alpha-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathwayS A Watson, K E Robinson, D McWilliams, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2005
Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine modelsR N Williams, S L Parsons, T M Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumideS A Watson, D L Morris, L G Durrant, et al.
Experimental and Molecular Pathology|February 1, 1981
Rubratoxin B hepatotoxicity: an electron microscopic studyV G Lockard, S A Watson, M Y Siraj, et al.
Anticancer Research|January 1, 1993
Interactions between oestradiol and danazol on the growth of gastrointestinal tumour cellsS A Watson, D M Crosbee, K L Dilks, et al.
Pageof 9